LifeStream Adds Neonatal, Pediatric Oxygenators With Polystan Acquisition
This article was originally published in The Gray Sheet
Executive SummaryThe addition of Polystan's SAFE Micro neonatal oxygenator to LifeStream's product line will help boost annual revenue by $15 mil. to over $100 mil. following the company's acquisition of the Vaerlose, Denmark-based company.
You may also be interested in...
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.